Pfizer forecasts COVID sales to surpass $50B – but investors still queasy
By Elisa Pfizer said on Tuesday it expects 2022 sales of its COVID-19 vaccine and antiviral pill to top $54 billion, but that fell short of lofty Wall Street estimates, …
Read More